The safest compliance approach is to strictly observe section 23.3 and thus be sure that the sterile packaging includes both the month and year of manufacture along with the time limit for using or implanting the device safely.
That said, if you are keenly intent on trying to avoid having both, then pose such approach to your Notified Body and/or Competent Authority. In so doing, there are some substantive legislative bases on which to stand:
- If EN ISO 20417 becomes harmonized with its current content which allows the sterile device label to include either the date by which it is safe to use or the date of manufacturer (for devices without a date by which it is safe to use), then that approach shall be allowed pursuant to Union MDR Article 8.
- Regardless of harmonization status, EN ISO 20417 (as amended) is the generally acknowledged state of the art (notwithstanding questionable exploitation of the slithery discussion in MDCG 2021-5). Proper consideration of the generally acknowledged state of the art is, and for decades has been, a preeminent requirement of European medical device legislation. Thus, I have a hard time believing or accepting the notion that regulators could care less about consideration of the generally acknowledged state of the art. Indeed, to be so flippant would directly put the regulators out of compliance with the legislative requirements of the Union MDR.
- Thus, regarding a device for which it is proposed that the expiry date rather than the manufacturing date would appear on the sterile packaging, Annex I(1) establishes that, taking into account the generally acknowledged state of the art [i.e., taking into account EN ISO 20417 (as amended) which doesn't require both dates], if the risk analysis shows that the device so labeled is safe and effective and doesn't compromise the clinical condition or the safety of patients, or the safety and health of users or, where applicable, other persons, and that any risks which may be associated with its use when so labeled constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, then that should be a compelling basis for the Notified Body and/or Competent Authority to authorize such sterile packaging information.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 13-Feb-2024 09:27
From: Robert van Boxtel
Subject: EU MDR labelling 23.3: Sterile packaging Information.
Don't we all!!
Unfortunately, the regulators could care less about what we consider state of the art regarding these type of issues.
On the other hand, there is a symbol for manufacturing date, so it is feasible to add both.
------------------------------
Robert van Boxtel
Principal Consultant Medical Device Project B.V.
MDProject
Alphen a/d Rijn
Netherlands
Original Message:
Sent: 13-Feb-2024 06:32
From: Richard Vincins
Subject: EU MDR labelling 23.3: Sterile packaging Information.
To further comment, yes it does say 'shall', but completely disagree with this approach since this is the only requirement in the world for this. More and more every day liking FDA's "least burdensome approach" - adding regulatory hurdles and content which is not needed.
------------------------------
Richard Vincins ASQ-CQA, MTOPRA, RAC
Principal Strategy Consultant
NAMSA
Original Message:
Sent: 13-Feb-2024 04:19
From: Christoph Kiesselbach
Subject: EU MDR labelling 23.3: Sterile packaging Information.
Hi Iker,
I agree with Robert that in this case the MDR seems quite clear that both are mandatory (use of "shall", no "where applicable" and section (i) ends with "and").
Best regards, Christoph
------------------------------
Christoph Kiesselbach
Schrack & Partner
Reutlingen
Germany
Original Message:
Sent: 12-Feb-2024 23:59
From: iker mallabiabarrena
Subject: EU MDR labelling 23.3: Sterile packaging Information.
Dear community,
My apologizes if the topic has already been discussed, but i could not found a clear response.
EU MDR GSPR 23.3 refers to information that shall appear on the "sterile packaging". 23.3 (h) refers to "month and year of manufacture" and 23.3 (i) refers to "use by date".
Q1) Is it mandatory to address both (manufacturing date AND use-by-date) on the sterile packaging?
or like on 23.2(j) Information on the label, we can use either "the date until when may be used safely" or "the date of manufacture".
Thanks in advance for your comments
BR
ik
------------------------------
iker mallabiabarrena
Regulatory Affairs
BD
Eysin
Switzerland
------------------------------